Galixir
Shenzhen
About Galixir
Galixir is an artificial intelligence technology to promote the research and development of new drugs. Our artificial intelligence drug discovery platform can help drug research and development scientists greatly save time and cost in drug development. At the same time, our platform also provides comprehensive patent protection coverage for the drugs developed. Relying on cutting-edge artificial intelligence technology, Xingyao combines engineering chemistry, computational chemistry, computational biology, and cloud computing technologies to serve the various processes of drug development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2020)
- Website: galixir.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Cloud Computing, Product Research
Social Profiles
Canonical: https://fsome.com/organization/galixir-70443 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.